Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.90 USD | -3.70% |
|
-5.19% | -4.70% |
Feb. 13 | Bristol Myers Squibb Cancer Treatment Misses Primary Endpoint in Trial | DJ |
Feb. 13 | Bristol-Myers Squibb's Melanoma Treatment Fails to Meet Primary Endpoint in Phase 3 Adjuvant Trial | MT |
Change | 5d. change | 1 months change | 3 months change | 1st Jan change | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
---|---|---|---|---|---|---|---|---|---|---|---|
-3.70% | -5.19% | -3.30% | -7.86% | -4.70% | +10.25% | -19.32% | -18.80% | -10.23% | 109B | ||
-3.00% | -3.88% | +13.34% | +7.38% | +9.36% | +11.48% | +259.74% | +498.26% | +1,096.53% | 760B | ||
-0.70% | +1.98% | +7.88% | +2.82% | +7.97% | +0.26% | -5.71% | +4.01% | +56.75% | 376B | ||
-1.50% | -11.35% | -5.88% | -25.80% | -10.69% | -34.17% | +73.38% | +155.70% | +293.99% | 349B | ||
-0.30% | +1.19% | +9.87% | +13.70% | +8.54% | +10.58% | +34.87% | +105.07% | +232.25% | 341B | ||
-1.11% | +1.90% | +11.81% | +12.58% | +15.26% | +29.62% | -13.94% | -13.53% | +19.38% | 264B | ||
-2.14% | +0.93% | +10.14% | +13.76% | +11.85% | +20.40% | +39.70% | +60.38% | +162.01% | 229B | ||
-1.67% | -4.89% | -16.70% | -15.61% | -16.56% | -34.02% | +8.55% | +0.44% | +41.15% | 210B | ||
-2.46% | -1.51% | +5.84% | +2.85% | +7.52% | +8.62% | +20.43% | -0.26% | -0.29% | 210B | ||
-1.16% | -0.81% | +9.01% | -1.61% | +11.71% | +0.38% | +29.83% | +30.28% | +89.71% | 157B | ||
-0.43% | -0.82% | -3.33% | -1.88% | -3.77% | -5.83% | -48.73% | -30.07% | -26.30% | 145B | ||
-1.58% | +0.33% | +11.22% | +9.85% | +10.63% | +20.96% | +12.47% | +12.42% | +20.98% | 136B | ||
-1.77% | +8.37% | +14.37% | +13.00% | +12.68% | +42.50% | +70.32% | +54.06% | +2.14% | 130B | ||
-0.06% | +4.75% | +6.63% | +1.70% | +3.60% | +28.43% | +83.34% | +82.80% | +531.44% | 78.46B | ||
-0.66% | -0.55% | +10.94% | +6.02% | +6.57% | -13.97% | -26.93% | -31.20% | -25.55% | 73.85B | ||
-.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | ||
-2.46% | -4.88% | -12.29% | -19.89% | -16.22% | -23.63% | +53.10% | +41.35% | +499.34% | 45.05B | ||
-1.79% | +1.29% | +4.69% | +6.16% | +1.83% | +21.54% | - | - | - | 43.88B | ||
-0.74% | +0.34% | +0.73% | -1.47% | -0.72% | -4.62% | +18.63% | -3.42% | -31.35% | 43.27B | ||
+1.93% | +0.46% | +2.73% | -6.09% | -0.87% | +8.67% | +14.47% | -28.43% | +371.74% | 39.89B | ||
Average | -1.10% | -0.55% | +4.09% | +0.51% | +2.84% | +5.13% | +33.57% | +51.06% | +184.65% | 190.1B | |
Weighted average by Cap. | -1.40% | -1.55% | +6.06% | +1.99% | +4.83% | +4.71% | +70.08% | +133.30% | +318.13% |
- Stock Market
- Equities
- BMY Stock
- Sector Bristol-Myers Squibb Company